Aligos Therapeutics (ALGS) EPS (Basic) (2019 - 2026)
Aligos Therapeutics' (ALGS) quarterly EPS (Basic) came in at -$2.21 in Q1 2026, down 143.22% YoY from $5.12 in Q1 2025, and down 10.12% on a QoQ basis from -$2.01 in Q4 2025.
Aligos Therapeutics (ALGS) EPS (Basic) (2019 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 8 years of EPS (Basic) data on file, last reported at -$2.21 in Q1 2026.
- Quarterly EPS (Basic) fell 143.22% year-over-year to -$2.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.68 (down 37.07% YoY) and the FY2025 annual result came in at -$2.45, up 88.31% from the prior year.
- EPS (Basic) declined to -$2.21 in Q1 2026, from -$2.01 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $5.12 in Q1 2025 to a low of -$20.94 in Q1 2022.
- A 5-year average of -$7.44 and a median of -$10.37 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 191.81% in 2025, down 289.49% in 2025.
- Tracing ALGS's EPS (Basic) over 5 years: stood at -$12.82 in 2022, then gained by 15.33% to -$10.85 in 2023, then slipped by 20.85% to -$13.11 in 2024, then surged by 84.66% to -$2.01 in 2025, then declined by 10.12% to -$2.21 in 2026.
- The last three EPS (Basic) figures came in at -$2.21 (Q1 2026), -$2.01 (Q4 2025), and -$3.04 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | Aligos Therapeutics | 69.36 Mn | 38.92 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Mar 31, 2026 | -2.21 |
| Dec 31, 2025 | -2.01 |
| Sep 30, 2025 | -3.04 |
| Jun 30, 2025 | -1.53 |
| Mar 31, 2025 | 5.12 |
| Dec 31, 2024 | -13.11 |
| Sep 30, 2024 | -3.07 |
| Jun 30, 2024 | 0.81 |
| Mar 31, 2024 | -5.58 |
| Dec 31, 2023 | -10.85 |
| Sep 30, 2023 | -10.37 |
| Jun 30, 2023 | -10.87 |
| Mar 31, 2023 | -13.37 |
| Dec 31, 2022 | -12.82 |
| Sep 30, 2022 | -10.89 |
| Jun 30, 2022 | -11.67 |
| Mar 31, 2022 | -20.94 |
| Dec 31, 2021 | -23.66 |
| Sep 30, 2021 | -19.53 |